Resistive Switching in Cr doped SrTiO3: An X-ray Absorption Spectroscopy study

Autor: Andreasson, B. P., Janousch, M., Staub, U., Meijer, G. I., Delley, B.

X-ray absorption spectroscopy was used to study the microscopic origin of conductance and resistive switching in chromium doped strontium titanate (Cr:SrTiO3). Differences in the x-ray absorption near edge spectroscopy (XANES) at the Cr K-edge indica

Externí odkaz: http://arxiv.org/abs/0707.0655

Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera-A matched nationwide population-based study.

Autor: Enblom-Larsson A; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden., Renlund H; Uppsala Clinical Research Centre Uppsala University, Uppsala, Sweden., Andréasson B; NU Hospital Group, Uddevalla, Sweden., Holmberg H; Department of Epidemiology and Global Health, Umeå University, Umeå, Sweden., Liljeholm M; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Själander A; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.

Publikováno v: British journal of haematology [Br J Haematol] 2024 May; Vol. 204 (5), pp. 1740-1751. Date of Electronic Publication: 2024 Feb 13.

Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event-A population based cohort study.

Autor: Larsson AE; Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden., Andréasson B; NU Hospital Group, Uddevalla, Sweden., Holmberg H; Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden., Liljeholm M; Department of Radiation Sciences, Umea University, Umea, Sweden., Själander A; Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden.

Publikováno v: European journal of haematology [Eur J Haematol] 2023 Jun; Vol. 110 (6), pp. 608-617. Date of Electronic Publication: 2023 Feb 12.

Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score.

Autor: Barbui T; FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy. tbarbui@fondazionefrom.it., Ghirardi A; FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy., Carobbio A; FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy., Masciulli A; FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy., Carioli G; FROM Research Foundation, ASST Papa Giovanni XXIII, Bergamo, Italy., Rambaldi A; ASST Papa Giovanni XXIII, Bergamo, Italy.; University of Milan, Milan, Italy., Finazzi MC; ASST Papa Giovanni XXIII, Bergamo, Italy.; University of Milan, Milan, Italy., Bellini M; ASST Papa Giovanni XXIII, Bergamo, Italy., Rumi E; Department of Molecular medicine, University of Pavia, Pavia, Italy.; Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Vanni D; Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Borsani O; Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Passamonti F; University of Insubria, Varese, Italy.; ASST Sette Laghi, Varese, Italy., Mora B; University of Insubria, Varese, Italy.; ASST Sette Laghi, Varese, Italy., Brociner M; ASST Sette Laghi, Varese, Italy., Guglielmelli P; CRIMM, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.; University of Florence, Florence, Italy., Paoli C; CRIMM, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.; University of Florence, Florence, Italy., Alvarez-Larran A; Hematology Department, Hospital Clínic, Barcelona, Spain., Triguero A; Hematology Department, Hospital Clínic, Barcelona, Spain., Garrote M; Hematopathology Unit, Pathology Department, Hospital Clínic, Barcelona, Spain., Pettersson H; Division of Hematology, NU Hospital Group, Uddevalla, Sweden., Andréasson B; Division of Hematology, NU Hospital Group, Uddevalla, Sweden., Barosi G; Center for the Study of Myelofibrosis, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy., Vannucchi AM; CRIMM, Azienda Ospedaliera Universitaria Careggi, Florence, Italy.; University of Florence, Florence, Italy.

Publikováno v: Blood cancer journal [Blood Cancer J] 2022 Nov 16; Vol. 12 (11), pp. 156. Date of Electronic Publication: 2022 Nov 16.

Survival and risk of vascular complications in myelofibrosis-A population-based study from the Swedish MPN group.

Autor: Lindgren M; Department of Medicine, Kalmar County Hospital, Kalmar, Sweden.; Faculty of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Andréasson B; Division of Hematology, Department of Medicine, NU Hospital Group, Uddevalla, Sweden., Samuelsson J; Department of Hematology, University Hospital Linköping, Linköping, Sweden., Pettersson H; Division of Hematology, Department of Medicine, NU Hospital Group, Uddevalla, Sweden., Enblom-Larsson A; Department of Public Health and Clinical Medicine, Luleå Research Unit, Umeå University, Umeå, Sweden., Ravn-Landtblom A; Department of Medicine, Karolinska Institute and Department of Medicine, Division of Hematology, Stockholm South Hospital, Stockholm, Sweden., Scheding S; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Lund University, Lund, Sweden.; Department of Hematology, Skåne University Hospital, Lund, Sweden., Bentham C; Department of Medicine, Varberg Hospital, Varberg, Sweden., Ahlstrand E; Department of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Publikováno v: European journal of haematology [Eur J Haematol] 2022 Oct; Vol. 109 (4), pp. 336-342. Date of Electronic Publication: 2022 Jun 24.